Invasive meningococcal disease in patients with complement deficiencies: a case series (2008–2017)

Investigational drugs in development to prevent neuromyelitis optica relapses

(2018) Friedemann Paul et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial

(2018) Sonoko Misawa et al.   LANCET NEUROLOGY

C3 glomerulonephritis secondary to mutations in factors H and I: rapid recurrence in deceased donor kidney transplant effectively treated with eculizumab

(2018) Neetika Garg et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis)

(2018) Christopher Sjöwall et al.   RHEUMATOLOGY

Epidemiology, clinical presentation, risk factors, intensive care admission and outcomes of invasive meningococcal disease in England, 2010–2015

(2018) Sydel R. Parikh et al.   VACCINE

Strains Responsible for Invasive Meningococcal Disease in Patients With Terminal Complement Pathway Deficiencies

(2017) Jérémie Rosain et al.   JOURNAL OF INFECTIOUS DISEASES

Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab

(2017) Sydel R. Parikh et al.   PEDIATRICS

Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study

(2016) Sydel R Parikh et al.   LANCET

Applying complement therapeutics to rare diseases

(2015) Edimara S. Reis et al.   CLINICAL IMMUNOLOGY

Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study

(2015) Dorothea M C Hill et al.   LANCET INFECTIOUS DISEASES

Eculizumab in the Treatment of Membranoproliferative Glomerulonephritis

(2015) Andrew S. Bomback   NEPHRON CLINICAL PRACTICE

Four-month outbreak of invasive meningococcal disease caused by a rare serogroup B strain, identified through the use of molecular PorA subtyping, England, 2013

(2014) C Chatt et al.   Eurosurveillance

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial

(2014) Robert C Read et al.   LANCET

Are complement deficiencies really rare? Overview on prevalence, clinical importance and modern diagnostic approach

(2014) Anete Sevciovic Grumach et al.   MOLECULAR IMMUNOLOGY

Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases

(2013) Carla M. Nester et al.   CURRENT OPINION IN PEDIATRICS

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

(2013) C.M. Legendre et al.   NEW ENGLAND JOURNAL OF MEDICINE

Meningococcal disease and the complement system

(2013) Lisa A Lewis et al.   Virulence

Meningococcal carriage by age: a systematic review and meta-analysis

(2010) Hannah Christensen et al.   LANCET INFECTIOUS DISEASES

Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease

(2010) Sonia Davila et al.   NATURE GENETICS

Meningococcal carriage and disease—Population biology and evolution

(2009) Dominique A. Caugant et al.   VACCINE

Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity

(2008) Martin C. J. Maiden et al.   JOURNAL OF INFECTIOUS DISEASES